No takes yet. Share an insight, caveat, or question.
CRISPR technology demonstrates potential in targeting monogenic and polygenic disorders, suggesting new gene therapies.
Ogunlakin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: